Plant-Based IBS Formulation via Composite Extracts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Irritable Bowel Syndrome (IBS) are inadequate, with high costs and significant side effects, and existing medications often focus on symptom relief rather than addressing the underlying neuropsychological and inflammatory aspects of the condition.
Innovation Solution
A plant-based formulation using a hydro-alcoholic extract of Acacia arabica, Nardostachys jatamansi, and Aegle marmelos, acting as a 5-HT3 antagonist and serotonin reuptake inhibitor, which regulates gut inflammation, pain, and neuropsychological symptoms, while improving stool consistency and overall well-being.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medications (SSRIs, anti-spasmodics, laxatives) are used for IBS management, then symptom relief is achieved, but side effects and treatment costs increase
Solution Approach 1:
The patent replaces expensive, long-term conventional medications with a cost-effective plant-based formulation that can be used continuously without accumulating harmful effects. The formulation uses natural ingredients (Babul, Jatamansi, Bilba extracts) that provide sustained relief without the side effects associated with synthetic drugs
Solution Approach 2:
The patent combines multiple plant extracts (Babul, Jatamansi, Bilba) in a composite formulation to achieve synergistic effects. This composite approach addresses multiple IBS symptoms simultaneously while avoiding the side effects of single-ingredient conventional medications
2Duration of action of stationary object
If conventional medications are prescribed for long-term IBS management, then symptom control is maintained, but treatment costs increase significantly
Solution Approach 1:
The plant-based formulation is positioned as a cost-effective alternative to expensive conventional medications. The natural ingredients are more affordable and can be used long-term without the financial burden of prescription drugs, while providing sustained symptom relief
3Ease of operation
If current treatments focus on symptom relief, then immediate comfort is provided, but underlying neuropsychological and inflammatory aspects remain unaddressed
Solution Approach 1:
The patent creates a multi-functional formulation that simultaneously addresses gastrointestinal symptoms, neuropsychological aspects (anxiety, depression), and inflammatory markers. The plant-based ingredients work on multiple pathways, providing comprehensive management rather than isolated symptom relief
4Object-affected harmful factors
If plant-based formulation is used, then side effects are minimized, but effectiveness in managing complex IBS symptoms may be reduced
Solution Approach 1:
The patent uses a composite of multiple plant extracts to enhance effectiveness while maintaining safety. The synergistic interaction between Babul, Jatamansi, and Bilba extracts provides comprehensive symptom management comparable to conventional medications without the harmful side effects
Solution Approach 2:
The natural plant-based formulation provides sustained effectiveness without the accumulation of harmful effects that occur with long-term use of synthetic medications. The formulation can be used continuously with minimal side effects while maintaining symptom control
Data Source
AI summary
The invention relates to a plant based formulation for the prevention and management of Irritable Bowel Syndrome (IBS) comprising of effective amount of a hydro-alcoholic extract of Acacia arabica, Aegle marmelos and Nardostachys jatamansi.